Related Experiment Videos
Growth inhibiting effect of estramustine on two prostatic carcinoma cell lines, LNCaP and LNCaP-r
M Hansenson1, B Lundh, B Hartley-Asp
1Department of Clinical Chemistry, Karolinska Institutet, Huddinge University Hospital, Sweden.
Abstract:
The effect of estramustine (EM), estradiol-17 beta (E2) or 5 alpha-dihydrotestosterone (DHT) on the growth of two human prostatic carcinoma cell lines, LNCaP and LNCaP-r was investigated. The hormone resistant subline LNCaP-r was derived in our laboratory, from the hormone sensitive LNCaP cell line. E2, 10(-8) or 10(-5) M inhibited the growth of the LNCaP cells, but did not affect the LNCaP-r. DHT, 10(-8) M, had a stabilizing effect at the stationary phase on the growth of the LNCaP cells whereas at higher concentrations, 10(-5) M, the growth rate was decreased. The LNCaP-r cell line was previously reported to be unaffected by DHT. EM inhibited the growth of both cell lines but LNCaP was more sensitive than LNCaP-r. E2 and DHT modulated the effect of EM. When treated with 10(-7) M EM, addition of E2 or DHT (10(-7)-10(-5) M) further inhibited the growth. When EM was used at a higher concentration (10(-5) M), the enhanced effect of growth inhibition by hormone addition was lost. Based on these results it is suggested that the presence of endogenous hormones, or estrogens released from EM on hydrolysis, may play a contributory role in the cytotoxicity of estramustine.
Insights
Estramustine inhibits prostate cancer cell growth, with estradiol and dihydrotestosterone modulating its effect. Hormone-resistant cells show less sensitivity, suggesting endogenous hormones may influence estramustine
Area of Science:
- Oncology
- Endocrinology
- Cell Biology
Background:
- Prostate carcinoma cell lines LNCaP and a hormone-resistant variant (LNCaP-r) were studied.
- Hormone sensitivity and resistance are critical factors in prostate cancer treatment.
Purpose of the Study:
- To investigate the effects of estramustine (EM), estradiol-17 beta (E2), and 5 alpha-dihydrotestosterone (DHT) on LNCaP and LNCaP-r cell growth.
- To determine if E2 and DHT modulate the cytotoxic effects of EM on these cell lines.
Main Methods:
- Cell culture of hormone-sensitive (LNCaP) and hormone-resistant (LNCaP-r) human prostate carcinoma cell lines.
- Treatment with varying concentrations of EM, E2, and DHT.
- Assessment of cell growth inhibition and modulation of EM's effects by hormones.
Main Results:
- E2 inhibited LNCaP cell growth but not LNCaP-r. DHT had a dose-dependent effect on LNCaP cell growth, with no effect on LNCaP-r.
- EM inhibited growth in both cell lines, with LNCaP being more sensitive. E2 and DHT enhanced EM's inhibitory effect at lower EM concentrations.
- This enhanced inhibition was lost at higher EM concentrations (10(-5) M).
Conclusions:
- Endogenous hormones or estrogens from EM hydrolysis may contribute to estramustine's cytotoxicity.
- Hormonal modulation plays a role in the efficacy of estramustine against prostate cancer cells.
- Understanding these interactions is crucial for optimizing prostate cancer therapy.